How Effective are Targeted Therapies and Immunotherapies?
Targeted therapies and immunotherapies have revolutionized the treatment of NSCLC, especially for patients with specific genetic mutations such as EGFR, ALK, and ROS1. Targeted therapies work by blocking the growth and spread of cancer cells, while immunotherapies boost the body's immune system to fight cancer. These treatments have shown significant efficacy and have improved survival rates for many patients.
